<DOC>
	<DOCNO>NCT00151333</DOCNO>
	<brief_summary>To determine safety tolerability multiple ascend fixed oral dos SRA-333 subject mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>Study Evaluating SRA-333 Mild Moderate Alzheimer 's Disease ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis probable AD accord NINCDSADRDA criterion . Men postmenopausal surgically sterile woman age 50 85 inclusive . Able give inform consent . Patient 's caregiver must consent participate study . Significant neurologic disease AD may affect cognition . Current clinically significant systemic illness likely deteriorate affect subject 's safety study . Other exclusion apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>